Effect of freezing, long-term storage, and microwave thawing on the stability of ketorolac tromethamine

Annals of Pharmacotherapy

Volumn 39, Issue 10, 2005, Pages 1654-1658

  Hecq, Jean Daniel ^a   Boitquin, Laurence P ^a   Vanbeckbergen, Danielle F ^a   Jamart, Jacques ^a   Galanti, Laurence M ^a  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

Drug stability; Freezing; HPLC; Infusion; Ketorolac; Microwave thawing

Indexed keywords

GLUCOSE; KETOROLAC TROMETAMOL; NONSTEROID ANTIINFLAMMATORY AGENT; POLYOLEFIN;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLOR; COST CONTROL; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG POTENCY; DRUG STABILITY; DRUG STORAGE; FREEZING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICROWAVE RADIATION; PH MEASUREMENT; PRECIPITATION; PRIORITY JOURNAL; QUALITY CONTROL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; DRUG STORAGE; FREEZING; KETOROLAC TROMETHAMINE; MICROWAVES; SOLUTIONS; TIME FACTORS;

EID: 25844525751     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G194     Document Type: Article

References (32)

1. Buckley MM, Brogden RN. Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 1990;39:86-109.
2. Litvak KM, McEvoy GK. Ketorolac, an injectable nonnarcotic analgesic. Clin Pharm 1990;3:921-35.
3. Koundalijan J. Setting up a CIVAS. In: Needle R, Sizer T. The CIVAS handbook. 1st ed. London: Pharmaceutical Press, 1998:1-5.
4. Vigneron J, Laurelli F, Phaypradith S, Perrin A, Hoffman MA, Hoffman M. Freezing of solutions for parenteral usage: advantages and disadvantages. Nine month's experience at the pharmacy of the Hospital of Nancy. J Pharm Belg 1992;47:504-22.
5. Boitquin L, Hecq J-D, Vanbeckbergen DF, Jamart J, Galanti LM. Stability of sufentanil citrate with levobupivacaine HCl in NaCl 0.9% infusion after microwave freeze-thaw treatment. Ann Pharmacother 2004;38: 1836-9. Epub 28 Sept 2004. DOI 10.1345/aph.1D564
6. Georget S, Vigneron J, Blaise N, Perrin A, Hoffman MA, Hoffman M. Stability of refrigerated and frozen solutions of tropisetron in either polyvinylchloride or polyolefin infusion bags. J Clin Pharm Ther 1997; 22:257-60.
7. Hecq JD, Berlage V, Vanbeckbergen D, Jamart J, Galanti L. Effects of freezing, long-term storage, and microwave thawing on the stability of piperacillin plus tazobactam in 5% dextrose for infusion. Can J Hosp Pharm 2004;57:276-82.
8. Hecq JD, Schlesser V, Vanbeckbergen D, Jamart J, Galanti L. Effects of freezing, long-term storage, and microwave thawing on the stability of cefuroxime sodium in 5% dextrose infusion polyvinyl chloride bags. Eur J Hosp Pharm-S 2005;1:23-5.
9. Lebrun J, Hecq J-D, Vanbeckbergen D, Jamart J, Galanti L. Effect of freezing, long-term storage and microwave thawing on the stability of tramadol in 5% dextrose infusion P.V.C. bags. Int J Pharmaceut Compound 2004;8:156-9.
10. Schlesser V, Hecq J-D, Vanbeckbergen D, Jamart J, Galanti L. Effect of freezing, long-term storage and microwave thawing on the stability of cefepime in 5% dextrose infusion P.V.C. bags. Int J Pharmaceut Compound 2002;6:391-4.
11. Sewell GJ, Palmer AJ. The chemical and physical stability of three intravenous infusions subjected to frozen storage and microwave thawing. Int J Pharm 1991;72:57-63.
12. Floy BJ, Royko CG, Fleitman JS. Compatibility of ketorolac tromethamine injection with common infusion fluids and administration sets. Am J Hosp Pharm 1990;47:1097-100.
13. Gupta VD, Maswoswe J. Stability of ketorolac tromethamine in 5% dextrose injection and 0.9% sodium chloride injection. Int J Pharmaceut Compound 1997;1:206-7.
14. Shi A, Walker SE, Law S. Stability of ketorolac tromethamine in IV solutions and waste reduction. Can J Hosp Pharm 2000;53:263-9.
15. Trissel LA. Drug stability and compatibility issues in drug delivery. In: Trissel LA. Handbook on injectable drugs, 11th ed. Bethesda, MD: American Society of Health-System Pharmacists, 2001:XII-XVII.
16. Thiesen J, Kramer I. Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in pvc bags and polyolefin containers. Pharm World Sci 1999;21:137-41.
17. Trissel LA, Pearson SD. Storage of lorazepam in three injectable solutions in polyvinyl chloride and polyolefin bags. Am J Hosp Pharm 1994;51:1825-6.
18. Norenberg JP, Achusim LE, Steel TH, Anderson TL. Stability of lorazepam in 0.9% sodium chloride stored in polyolefin bags. Am J Health Syst Pharm 2004;61:1039-41.
19. Zhang Y, Xu QA, Trissel LA, Gilbert DL, Martinez JF. Compatibility and stability of paclitaxel combined with cisplatin and with carboplatin in infusion solutions. Ann Pharmacother 1997;31:1465-70.
20. Trissel LA, Xu QA, Gilbert DL. Compatibility and stability of paclitaxel combined with doxorubicin hydrochloride in infusion solutions. Ann Pharmacother 1998;32:1013-6. DOI 10.1345/aph.17400
21. Xu QA, Trissel LA, Zhang Y, Martinez JF, Gilbert DL. Stability of thiotepa (lyophilized) in 5% dextrose injection at 4 and 23 degrees C. Am J Health Syst Pharm 1996;53:2728-30.
22. Craig SB, Bhatt UH, Patel K. Stability and compatibility of topotecan hydrochloride for injection with common infusion solutions and containers. J Pharm Biomed Anal 1997;16:199-205.
23. Kleinberg ML, Chang P. Overfill of common piggybag admixture solutions. Hosp Pharm 1984;19:657-8.
24. Food and Drug Administration. Documentation for stability of human drugs and biologies. Rockville, MD: Center for Drugs and Biologies, 1987. www.fda.gov/cder/guidance/cmc2.pdf (accessed 2005 Feb 2).
25. Ruberg SJ, Stegeman JW. Pooling data for stability studies: testing the equality of batch degradation slopes. Biometrics 1991;47:1059-69.
26. Trissel LA. The new National Standard for sterile preparation. Hosp Pharm 2004;39:900-4.
27. Galanti LM, Hecq JD, Vanbeckbergen D, Jamart J. Long-term stability of cefuroxime and cefazolin sodium in intravenous infusions. J Clin Pharm Ther 1996;21:185-9.
28. Galanti LM, Hecq JD, Vanbeckbergen D, Jamart J. Long-term stability of vancomycin hydrochloride in intravenous infusions. J Clin Pharm Ther 1997;22:353-6.
29. Galanti LM, Hecq JD, Jeuniau PH, Vanbeckbergen D, Jamart J. Assessment of the stability of teicoplanin in intravenous infusions. Int J Pharmaceut Compound 2001;5:397-400.
30. Boitquin L, Hecq JD, Evrard JM, Vanbeckbergen D, Jamart J, Galanti L. Long-term stability of sufentanil citrate with levobupivacaine hydrochloride in 0.9% sodium chloride infusion PVC bags at 4 degrees C. J Pain Symptom Manage 2004;28:4-6.
31. Delaney T. EAHP survey of hospital-based pharmaceutical services in Europe-1996. Eur Hosp Pharm 1996;2:92-105.
32. Hecq JD. Ten years of European hospital pharmacy history: centralized intravenous additives services. Eur J Hosp Pharm 2004;10:47.